Léa Bignon, “Pharmaceuticals and Digital Health: Evidence from Data-driven Insights on the Insulin Market”, TSE Working Paper, n. 26-1743, April 2026.
Pierre Dubois, and Ariel Pakes, “Pharmaceutical Advertising in Dynamic Equilibrium”, TSE Working Paper, n. 26-1729, February 2026, revised May 2026.
Pierre Dubois, “Pharmaceutical Regulation and Incentives for Innovation in an International Perspective”, TSE Working Paper, n. 25-1674, October 2025, revised December 2025.
Helmuth Cremer, and Firouz Gahvari, “Endogenous altruism and long term care policies in a Mirrleesian setting”, TSE Working Paper, n. 25-1626, March 2025.
Matthew Adler, Maddalena Ferranna, James K. Hammitt, Eugénie de Laubier, and Nicolas Treich, “Fair Innings: An Empirical Test”, TSE Working Paper, n. 25-1630, March 2025.
Ilaria Natali, “Invisible Threat: How Airborne Pollution Fuels Antimicrobial Resistance in the EU”, TSE Working Paper, n. 25-1610, January 2025.
Manh-Hung Nguyen, Viet-Ngu Hoang, Son Nghiem, and Lan Anh Nguyen, “The Dynamic and Heterogeneous Effects of COVID-19 Vaccination Mandates in the USA”, TSE Working Paper, n. 24-1598, November 2024.
Claire Borsenberger, Helmuth Cremer, Denis Joram, Jean-Marie Lozachmeur, and Estelle Malavolti, “The design of insurance contracts for home versus nursing home Long-Term Care”, TSE Working Paper, n. 24-1528, April 2024, revised November 2025.
David Bardey, Philippe De Donder, and Vera Zaporozhets, “Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review”, TSE Working Paper, n. 24-1507, February 2024, revised September 2025.